Intensity-Modulated Proton Therapy MarketSize and Trends

Global Intensity-Modulated Proton Therapy Market- Impact of COVID-19

The COVID-19 pandemic has impacted growth of various markets, and it is also expected to hamper the growth of the global intensity modulated proton therapy market during 2020. The pandemic has directly affected demand for the intensity modulated proton therapy as cancer patients are at higher risk of getting infected by COVID-19. Moreover, implementation of nationwide lockdown in several countries and safety precautions suggested by World Health Organization to decrease the risk of spread of COVID-19 while performing treatments and therapy procedures has made it difficult to administer therapy in cancer patients. As a result, the COVID-19 pandemic is expected to hamper growth of the global intensity modulated proton therapy market.

Global Intensity-Modulated Proton Therapy Market- Drivers

The rising prevalence of non-communicable diseases such as cancer is a major burden globally. According to the World Health Organization, cancer accounted for around 9.6 million deaths across the globe in 2018. Moreover, healthcare facilities are focusing on adoption of intensity modulated proton therapy due to its safety and efficiency in treatment of cancer. In February 2020, IBA Ion Bean Application announced that they have signed a contract to install Proteus ONE, a compact proton therapy at RSPAD Gatot Soebroto Presidential Hospital in Jakarta, Indonesia.